Biovotion appoints new Chairman of the Board

Biovotion is pleased to announce Dr. Markus Christen as new Chairman of the board. Markus is a senior executive in the digital health, pharmaceuticals and life sciences industries with extensive experience in patient outcomes approaches and real word evidence initiatives. In the last 8 years, he has been highly engaged in Digital Health. Most recently he served as SVP Global Head of Development and Alliance Management at Proteus Digital Health, a pioneer in Digital Health and first Unicorn in this sector out of Silicon Valley.

After nearly 12 months of beta field testing, the company has now transitioned into a broader commercialisation of its Everion platform. Together with Markus we are looking forward to enter this next stage of Biovotion’s growth and continue to unfold the real-world deployment and commercialization of our revolutionary Everion platform. For that next step Biovotion is very excited to benefit from Markus’ highly relevant experiences he has made in this arena.

Last week Medical Marketing and Media nominated Markus amongst the top 40 executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological era.

Dr. Gerd Meyer has supported the company for more than 5 years, predominantly as Chairman of the Board and then as Board member. Last year he has indicated his wish to pass on the role of his Board seat to a new generation and do a stepwise hand over.
In the name of the Board of Directors and the shareholders of Biovotion I would like to express gratitude to Gerd for providing his expertise and guidance over those years. We have enjoyed a very constructive and professional partnership with Gerd and I would like to thank him very much for that.

Together with our team, I now look forward to focus again on my role as CEO, to aggressively pursue our vision in Digital Health.

Andreas Caduff, Founder & CEO